| References |
|
|
Abe J,
Onimaru M,
Matsumoto S et al.
(1997)
Clinical role for a superantigen in Yersinia pseudotuberculosis infection.
Journal of Clinical Investigation
99:
18231830.
|
|
|
Altmann D
(2005)
Antagonist peptide for the treatment of bacterial superantigen toxic shock in a clinical or biowarfare setting.
Expert Opinion on Therapeutic Patents
15:
741743. doi:10.1517/13543776.15.6.741.
|
|
|
Alvarez-Ossorio L,
Johannsen M,
Alvarez-Ossorio R et al.
(1998)
Cytokine induction by Mycoplasma arthritidis-derived superantigen (MAS), but not by TSST-1 or SEC-3, is correlated to certain HLA-DR types.
Scandinavian Journal of Immunology
47:
4347.
|
|
|
Arad G,
Levy R,
Hillman D and
Kaempfer R
(2000)
Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Nature Medicine
6:
414421.
|
|
|
Balaban N and
Rasooly A
(2000)
Staphylococcal enterotoxins.
International Journal of Food Microbiology
61:
110.
|
|
|
Carnoy C,
Mullet C,
Muller-Alouf H,
Leteurtre E and
Simonet M
(2000)
Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice.
Infection and Immunity
68:
25532559.
|
|
|
Choi Y,
Kappler JW and
Marrack P
(1991)
A superantigen encoded in the open reading frame of the 3¢ long terminal repeat of mouse mammary tumour virus.
Nature
350:
203207.
|
|
|
Cole BC,
Tuller JW and
Sullivan GJ
(1987)
Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. VI. Detection of a non-MHC gene(s) in the E alpha-bearing RIIIS mouse strain that is associated with a specific lack of T cell responses to the M. arthritidis soluble mitogen.
Journal of Immunology
139:
927935.
|
|
|
Conrad B,
Weissmahr RN,
Boni J et al.
(1997)
A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes.
Cell
90:
303313.
|
|
|
Fraser JD and
Proft T
(2008)
The bacterial superantigen and superantigen-like proteins.
Immunological Reviews
225:
226243.
|
|
|
Fujiwaka H,
Igarashi H,
Usami H,
Tanaka S and
Tamura H
(1986)
Clearance of endotoxin from blood of rabbits injected with staphylococcal toxic shock syndrome toxin-1.
Infection and Immunity
52:
134137.
|
|
|
Hassan SM and
Doolittle BR
(2009)
A case of Yersinia enterocolitica mimicking Kawasaki disease.
Rheumatology (Oxford)
48:
857858.
|
|
|
Held W,
Waanders GA,
Shakhov AN et al.
(1993)
Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission.
Cell
74:
529540.
|
|
|
Hong-Geller E,
Mollhoff M,
Shiflett PR and
Gupta G
(2004)
Design of chimeric receptor mimics with different TcRV beta isoforms Type-specific inhibition of superantigen pathogenesis.
Journal of Biological Chemistry
279:
56765684.
|
|
|
Hovde CJ,
Marr JC,
Hoffmann ML et al.
(1994)
Investigation of the role of the disulphide bond in the activity and structure of staphylococcal enterotoxin C1.
Molecular Microbiology
13:
897909.
|
|
|
Hsu PN,
Wolf Bryant P,
Sutkowski N et al.
(2001)
Association of mouse mammary tumor virus superantigen with MHC class II during biosynthesis.
Journal of Immunology
166:
33093314.
|
|
|
Kappler JW,
Staerz U,
White J and
Marrack PC
(1988)
Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex.
Nature
332:
3540.
|
|
|
Konishi N,
Baba K,
Abe J et al.
(1997)
A case of Kawasaki disease with coronary artery aneurysms documenting Yersinia pseudotuberculosis infection.
Acta Paediatrica
86:
661664.
|
|
|
Kotb M
(1995)
Bacterial pyrogenic exotoxins as superantigens.
Clinical Microbiology Reviews
8:
411426.
|
|
|
Krakauer T
(2010)
Therapeutic down-modulators of Staphylococcal superantigen-induced inflammation and toxic shock.
Toxins
2:
19631983.
|
|
|
Lafon M
(1993)
Rabies virus superantigen.
Research in Immunology
144:
209213.
|
|
|
Langley R,
Patel D,
Jackson N,
Clow F and
Fraser JD
(2010)
Staphylococcal superantigen super-domains in immune evasion.
Critical Reviews in Immunology
30:
149165.
|
|
|
Leung DY
(1996)
Superantigens related to Kawasaki syndrome.
Springer Seminars in Immunopathology
17:
385396.
|
|
|
Lina G,
Bohach GA,
Nair SP et al.
(2004)
Standard nomenclature for the superantigens expressed by Staphylococcus.
Journal of Infectious Diseases
189:
23342336.
|
|
|
Liu L,
Li Z and
Guo Y
(2010)
Crystal structure of the Mycoplasma arthritidis-derived mitogen in apo form reveals a 3D domain-swapped dimer.
Journal of Molecular Biology
399:
367376.
|
|
|
Llewelyn M and
Cohen J
(2002)
Superantigens: microbial agents that corrupt immunity.
Lancet Infectious Diseases
2:
156162.
|
|
|
MacDonald HR,
Baschieri S and
Lees RK
(1991)
Clonal expansion precedes anergy and death of V beta 8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo.
European Journal of Immunology
21:
19631966.
|
|
|
MacDonald HR,
Schneider R,
Lees RK et al.
(1988)
T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens.
Nature
332:
4045.
|
|
|
McCormick JK,
Yarwood JM and
Schlievert PM
(2001)
Toxic shock syndrome and bacterial superantigens: an update.
Annual Review of Microbiology
55:
77104.
|
|
|
Mitchell DT,
Levitt DG,
Schlievert PM and
Ohlendorf DH
(2000)
Structural evidence for the evolution of pyrogenic toxin superantigens.
Journal of Molecular Evolution
51:
520531.
|
|
|
Murzin AG
(1993)
OB(oligonucleotide/oligosaccharide binding)-fold: common structural and functional solution for non-homologous sequences.
EMBO Journal
12:
861867.
|
|
|
Ohmen JD,
Barnes PF,
Grisso CL,
Bloom BR and
Modlin RL
(1994)
Evidence for a superantigen in human tuberculosis.
Immunity
1:
3543.
|
|
|
Perron H,
Jouvin-Marche E,
Michel M et al.
(2001)
Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation.
Virology
287:
321332.
|
|
|
Proft T and
Fraser JD
(2007)
Streptococcal superantigens.
Chemical Immunology and Allergy
93:
123.
|
|
|
Saha B,
Harlan DM,
Lee KP,
June CH and
Abe R
(1996a)
Protection against lethal toxic shock by targeted disruption of the CD28 gene.
Journal of Experimental Medicine
183:
26752680.
|
|
|
Saha B,
Jaklic B,
Harlan DM et al.
(1996b)
Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
Journal of Immunology
157:
38693875.
|
|
|
Schlievert PM
(1982)
Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.
Infection and Immunity
36:
123128.
|
|
|
Sicat J,
Sutkowski N and
Huber BT
(2005)
Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis.
Journal of Rheumatology
32:
18211831.
|
|
|
Stauffer Y,
Marguerat S,
Meylan F et al.
(2001)
Interferon-alpha-induced endogenous superantigen: a model linking environment and autoimmunity.
Immunity
15:
591601.
|
|
|
Stuart PM,
Munn RK,
DeMoll E and
Woodward JG
(1995)
Characterization of human T-cell responses to Yersinia enterocolitica superantigen.
Human Immunology
43:
269275.
|
|
|
Sundberg EJ,
Deng L and
Mariuzza RA
(2007)
TCR recognition of peptide/MHC class II complexes and superantigens.
Seminars in Immunology
19:
262271.
|
|
|
Sutkowski N,
Conrad B,
Thorley-Lawson DA and
Huber BT
(2001)
Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen.
Immunity
15:
579589.
|
|
|
book
Tai AK and
Huber BT
(2007)
"Viral superantigens in mice and humans".
In: Kotb M and
Fraser JD (eds)
Superantigens: Molecular Basis for Their Role in Human Diseases,
pp. 5975.
Washington, DC: ASM Press.
|
|
|
Tai AK,
Luka J,
Ablashi D and
Huber BT
(2009)
HHV-6A infection induces expression of HERV-K18-encoded superantigen.
Journal of Clinical Virology
46:
4748.
|
|
|
Tai AK,
O'Reilly EJ,
Alroy KA et al.
(2008)
Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis.
Multiple Sclerosis
14:
11751180.
|
|
|
Todd J,
Fishaut M,
Kapral F and
Welch T
(1978)
Toxic-shock syndrome associated with phage-group-I Staphylococci.
Lancet
2:
11161118.
|
|
|
Todd JK
(2011)
Toxic shock syndrome evolution of an emerging disease.
Advances in Experimental Medicine and Biology
697:
175181.
|
|
|
Turcanova VL,
Bundgaard B and
Hollsberg P
(2009)
Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigen.
Journal of Clinical Virology
46:
1519.
|
|
|
Wang N,
Mattis DM,
Sundberg EJ,
Schlievert PM and
Kranz DM
(2010)
A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes.
Clinical and Vaccine Immunology
17:
17811789.
|
|
|
White J,
Herman A,
Pullen AM et al.
(1989)
The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice.
Cell
56:
2735.
|
|
|
Wucherpfennig KW
(2001)
Mechanisms for the induction of autoimmunity by infectious agents.
Journal of Clinical Investigation
108:
10971104.
|
|
|
Yeung RSM
(2004)
The etiology of Kawasaki disease: a superantigen-mediated process.
Progress in Pediatric Cardiology
19:
115122.
|
| Further Reading |
|
|
book
Kotb M and
Fraser JD (eds)
(2007)
Superantigens: Molecular Basis and Role in Human Disease. ISBN 978-1-55581-3.
Washington, DC: ASM Press.
|
|
|
book
Krakauer T (ed.)
(2002)
Superantigen Protocols (Methods in Molecular Biology). ISBN: 0896039846.
Totowa, NJ: Humana Press.
|
|
|
book
Marone G (ed.)
(2007)
Superantigens and Superallergens. ISBN 9783805582667.
Basel: Karger.
|
|
|
Stow NW,
Douglas R,
Tantilipikorn P and
Lacroix JS
(2010)
Superantigens.
Otolaryngologic Clinics of North America
43(3):
489502, vii.
|